Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for Maravai Lifesciences Holdings (MRVI) over the last 4 years, with Q3 2025 value amounting to $243.6 million.

  • Maravai Lifesciences Holdings' Cash & Current Investments fell 5787.06% to $243.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.6 million, marking a year-over-year decrease of 5787.06%. This contributed to the annual value of $323.8 million for FY2024, which is 4368.78% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Cash & Current Investments of $243.6 million as of Q3 2025, which was down 5787.06% from $269.9 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Cash & Current Investments high stood at $632.1 million for Q4 2022, and its period low was $243.6 million during Q3 2025.
  • Its 4-year average for Cash & Current Investments is $473.5 million, with a median of $575.0 million in 2023.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Cash & Current Investments dropped by 7.41% in 2024 and then tumbled by 5787.06% in 2025.
  • Over the past 4 years, Maravai Lifesciences Holdings' Cash & Current Investments (Quarter) stood at $632.1 million in 2022, then dropped by 9.04% to $575.0 million in 2023, then tumbled by 43.69% to $323.8 million in 2024, then decreased by 24.77% to $243.6 million in 2025.
  • Its Cash & Current Investments stands at $243.6 million for Q3 2025, versus $269.9 million for Q2 2025 and $285.1 million for Q1 2025.